You are here

stroke

DiaMedica prepares to end 10-month FDA hold on late-phase stroke trial by halving dose

DiaMedica prepares to end 10-month FDA hold on late-phase stroke trial by halving dose

Fierce Biotech

DiaMedica Therapeutics

clinical trials

Flag link:

Busy with 3 program launches this year, Biogen trims pipeline

Busy with 3 program launches this year, Biogen trims pipeline

Fierce Biotech

Flag link:

Shionogi starts global Phase II clinical trial of redasemtide

Shionogi starts global Phase II clinical trial of redasemtide

Clinical Trials Arena

clinical trials

Flag link:

Could This Drug Candidate Be a Winner for These 2 Big Pharma Stocks?

Could This Drug Candidate Be a Winner for These 2 Big Pharma Stocks?

Motley Fool

clinical trials

Bristol Myers Squibb

Flag link:

FDA clears Pharmazz’s IND for acute cerebral ischaemic stroke therapy trial

FDA clears Pharmazz’s IND for acute cerebral ischaemic stroke therapy trial

Clinical Trials Arena

cerebral ischemia

Flag link:

FDA reports initial 'no signal' for stroke risk with Pfizer boosters, launches concomitant flu shot study

FDA reports initial 'no signal' for stroke risk with Pfizer boosters, launches concomitant flu shot study

Endpoints

bivalent boosters

Flag link:

U.S. FDA, CDC see early signal of possible Pfizer bivalent COVID shot link to stroke

U.S. FDA, CDC see early signal of possible Pfizer bivalent COVID shot link to stroke

Yahoo/Reuters

bivalent boosters

Flag link:

Influenza vaccination reduces the risk of stroke

Influenza vaccination reduces the risk of stroke

Clinical Trials Arena

Flag link:

Medtronic Teases Collaboration Platform for Stroke Innovation

Medtronic Teases Collaboration Platform for Stroke Innovation

Medical Devices and Diagnostics Industry

Flag link:

Penumbra’s catheters achieve first-pass revascularization in 68.9% of stroke patients

Penumbra’s catheters achieve first-pass revascularization in 68.9% of stroke patients

Medtech Dive

RED reperfusion catheters

ischemic stroke

revascularization

Flag link:

Boston Scientific touts early results of real-world Watchman FLX study

Boston Scientific touts early results of real-world Watchman FLX study

Medtech Dive

Boston Scientific

real world data

real world evidence

atrial fibrillation

Flag link:

Vagal nerve stimulator for stroke rehab nabs FDA nod

Vagal nerve stimulator for stroke rehab nabs FDA nod

RAPS.org

vagal nerve stimulation

chronic ischemic stroke

MicroTransponder

Flag link:

Could These 3 Potential Blockbusters Transform Biogen?

Could These 3 Potential Blockbusters Transform Biogen?

Motley Fool

Alzheimer's disease

Flag link:

Boston Scientific's Watchman shows low stroke rate in large registry at ACC

Boston Scientific's Watchman shows low stroke rate in large registry at ACC

Medtech Dive

Boston Scientific

atrial fibrillation

Flag link:

Biogen buys midphase drug to challenge Roche for stroke market

Biogen buys midphase drug to challenge Roche for stroke market

Fierce Biotech

acute ischemic stroke

Flag link:

FDA greenlights device to retrain muscles in stroke patients

FDA greenlights device to retrain muscles in stroke patients

Medtech Dive

Flag link:

AZ’s Brilinta reduced rate of stroke and death in high-risk subgroup

AZ’s Brilinta reduced rate of stroke and death in high-risk subgroup

Pharma Times

clinical trials

Flag link:

Go or no go? Vaccine panel upstages US approval decisions

Go or no go? Vaccine panel upstages US approval decisions

EP Vantage

Kala Pharmaceuticals

dry eye disease

Flag link:

AstraZeneca's Brilinta looks for label boost with trial win, priority review in stroke patients

AstraZeneca's Brilinta looks for label boost with trial win, priority review in stroke patients

Fierce Pharma

clinical trials

Flag link:

Tamping down stroke damage with a drug that protects brain cells

Tamping down stroke damage with a drug that protects brain cells

Fierce Biotech

University of Pittsburgh

Flag link:

Pages